Donald A. Denkhaus, Director at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 20,000 shares at $16.59 ($332K) on 2022-11-11, disclosed to the SEC on 2022-11-15.
Open-market sale of $332k CPRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CPRX | BUY | 2018-12-17 | $149K | — | Filing → |
| CPRX | BUY | 2018-06-11 | $68K | — | Filing → |
| CPRX | BUY | 2018-05-31 | $75K | — | Filing → |